CD8A and neoplasm: It also significantly inhibited the accumulation of MDSCs, leading to restoration of the IFN-γ level inhibited by MDSCs, enhancement the activity of CD8+ T-cells, and improvement of the ratio of CD4(+) to CD8(+) T-cells (136), which is beneficial to the improvement of the immune system’s attack on tumor cells.